Participants:0–17 years · 18–64 years · 65+ years
Substances:[4-(6-Aminopyridazin-3-Yl)Piperidin-1-Yl][5-(4-Fluorophenoxy)-4-Methoxypyridin-2-Yl]Methanone

Contact Research Centre

Chronic spontaneous urticaria

Recruiting

Registered drugNo placebo

A study to evaluate the long-term safety and effectiveness of barzolvolimab in patients with chronic spontaneous urticaria

Registered drugNo placebo

Portugal

Participants:18–64 years · 65+ years
Substances:Barzolvolimab

Contact Research Centre

Colorectal cancer metastatic

Recruiting

Registered drugNo placebo

Study of Sotorasib, Panitumumab and a drug combination for patients with metastatic colorectal cancer with KRAS p.G12C mutation.

Registered drugNo placebo

Portugal

Participants:18–64 years
Substances:Bevacizumab

Contact Research Centre

Hereditary angioedema with C1 esterase inhibitor deficiency+1

Recruiting

Investigational

A study of navenibart for long-term safety in patients with hereditary angioedema

Investigational

Portugal

Participants:0–17 years · 18–64 years · 65+ years
Substances:NAVENIBART

Contact Research Centre

Cardiovascular disorder+1

Recruiting

Investigational

Study of Zilebesiran Added to Standard Treatment to Reduce Heart Problems in Adults with High Blood Pressure and Heart Disease Risk

Investigational

Portugal

Participants:18–64 years · 65+ years
Substances:ZILEBESIRAN

Contact Research Centre

Dementia Alzheimer's type

Recruiting

InvestigationalNo placebo

Study of trospium chloride and xanomeline tartrate combination for agitation in Alzheimer's disease patients: Long-term safety evaluation

InvestigationalNo placebo

Portugal

Participants:18–64 years · 65+ years
Substances:Trospium Chloride

Contact Research Centre

Vitiligo

Recruiting

Investigational

Study of ruxolitinib cream for children aged 6 to 12 years with non-segmental vitiligo

Investigational

Portugal

Participants:0–17 years
Substances:Ruxolitinib

Contact Research Centre

Cardiovascular disorder+2

Recruiting

Registered drug

Study of vicadrostat and empagliflozin combination in patients with type 2 diabetes, high blood pressure and cardiovascular disease

Registered drug

Portugal

Participants:18–64 years · 65+ years
Substances:Bi 690517

Contact Research Centre

Bronchiectasis

Recruiting

Investigational

Study of BI 1291583 tablets taken once daily for 76 weeks in adults with bronchiectasis

Investigational

Portugal

Participants:0–17 years · 18–64 years · 65+ years
Substances:Bi 1291583

Contact Research Centre

Arteriosclerosis

Recruiting

Investigational

Study of maridebart cafraglutide to reduce cardiovascular problems in overweight or obese patients with atherosclerotic cardiovascular disease

Investigational

Portugal

Participants:18–64 years · 65+ years
Substances:Maridebart Cafraglutide

Contact Research Centre

Psoriatic arthropathy

Recruiting

Registered drug

Study of Zasocitinib and Apremilast for Adults with Active Psoriatic Arthritis Who Have Not Used Biologic Medicines

Registered drug

Portugal

Participants:18–64 years · 65+ years
Substances:Apremilast

Contact Research Centre

Find therapies in clinical trials near you

258 trials match your criteria

Psoriatic arthropathy

Long-Term Safety and Efficacy of Zasocitinib in Adults with Active Psoriatic Arthritis

Focal segmental glomerulosclerosis

A study to evaluate the effects of BI 764198 in adults and adolescents with focal segmental glomerulosclerosis (FSGS)

Chronic spontaneous urticaria

A study to evaluate the long-term safety and effectiveness of barzolvolimab in patients with chronic spontaneous urticaria

Colorectal cancer metastatic

Study of Sotorasib, Panitumumab and a drug combination for patients with metastatic colorectal cancer with KRAS p.G12C mutation.

Hereditary angioedema with C1 esterase inhibitor deficiency+1

A study of navenibart for long-term safety in patients with hereditary angioedema

Cardiovascular disorder+1

Study of Zilebesiran Added to Standard Treatment to Reduce Heart Problems in Adults with High Blood Pressure and Heart Disease Risk

Dementia Alzheimer's type

Study of trospium chloride and xanomeline tartrate combination for agitation in Alzheimer's disease patients: Long-term safety evaluation

Vitiligo

Study of ruxolitinib cream for children aged 6 to 12 years with non-segmental vitiligo

Cardiovascular disorder+2

Study of vicadrostat and empagliflozin combination in patients with type 2 diabetes, high blood pressure and cardiovascular disease

Bronchiectasis

Study of BI 1291583 tablets taken once daily for 76 weeks in adults with bronchiectasis

Arteriosclerosis

Study of maridebart cafraglutide to reduce cardiovascular problems in overweight or obese patients with atherosclerotic cardiovascular disease

Psoriatic arthropathy

Study of Zasocitinib and Apremilast for Adults with Active Psoriatic Arthritis Who Have Not Used Biologic Medicines

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.